Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials
Li X, Long J, Gao Q, Pan M
Published in Nutrition Reviews
Key Findings
Nattokinase reduced total cholesterol, LDL and systolic blood pressure modestly across randomised trials, with heterogeneity and small trial sizes.
Conclusions
Consistent but small cardiometabolic effects.
Limitations
Predominantly small Asian trials.
Supplements Studied
Nattokinase reduced total cholesterol, LDL and systolic blood pressure modestly across randomised trials.
Outcomes Measured
Pooled randomised trials showed modest systolic blood pressure lowering with nattokinase.
Total cholesterol and LDL fell modestly with nattokinase supplementation.
Nattokinase reduced total cholesterol, LDL and systolic blood pressure modestly across randomised trials, with heterogeneity and small trial sizes.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.